View the basic RJF option chain and compare options of Raymond James Financial, Inc. on Yahoo Finance.

Investing.com -- Raymond James has updated its Healthcare Top Picks list for October, adding three new stocks while removing others from the monthly selection. The firm added Xencor, Calyxt, and UnitedHealth Group to replace Relay Therapeutics, Tyra Biosciences, and Oscar Health.

August assets reached USD 1.97 trillion, up 16.00 percent year over year. Raymond James stock costs

Raymond James Financial Inc (NYSE:RJF) recently announced a total dividend of $0.54 per share, with the ex-dividend date set for 2026-10-01. This amount consists entirely of a $0.54 per share cash dividend, payable on 2026-10-15. For income-focused investors, the ex-dividend date is a key marker: shareholders must own the stock before that date to qualify for the payment.

Raymond James stock was at EUR 139.95 after-hours at 8:19 p.m. CEST on September 30, 2026, down 0.71

Raymond James stock was at EUR 140.70 versus EUR 140.95, down 0.18 percent, on September 30, 2026. Q

Raymond James stock was at EUR 141.20 pre-market at Lang & Schwarz on September 30, 2026, up 0.18 pe

Raymond James stock was EUR 141.55 at Lang & Schwarz on September 29, 2026, versus EUR 141.73 previo

Follow Raymond James Financial as investors assess wealth management and investment banking, the current catalyst, execution risks and the company evidence that may shape its next market move.

Las acciones de Raymond James cotizaban a 159,87 dólares el 25 de septiembre de 2026, mientras que los ingresos trimestrales alcanzaron los dólares.

Envestnet Asset Management Inc. reduced its stake in Raymond James Financial, Inc. (NYSE:RJF - Free Report) by 7.3% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 472,067 shares of the financial services provider

Shares of Raymond James Financial, Inc. (NYSE:RJF - Get Free Report) have earned a consensus recommendation of "Hold" from the fourteen brokerages that are presently covering the firm, Marketbeat.com reports. Nine research analysts have rated the stock with a hold rating and five have assigned a buy

Iowa's Greenwood Wealth Partners exits D.M. Kelly as UBS and Ameriprise win Merrill Lynch recruits in California and Florida

Raymond James stock stood at USD 160.76 on September 25, 2026, after a USD 2.00 rise. Market value w

At the close on September 24, 2026, Raymond James stock finished at USD 158.23, while the Nasdaq Com